online discount medstore
advair diskus for sale
buy advair diskus without prescription
allegra for sale
buy allegra without prescription
aristocort for sale
buy aristocort without prescription
astelin for sale
buy astelin without prescription
atarax for sale
buy atarax without prescription
benadryl for sale
buy benadryl without prescription
buy clarinex without prescription
clarinex for sale
buy claritin without prescription
claritin for sale
buy flonase without prescription
flonase for sale
buy ventolin without prescription
ventolin for sale
amoxil for sale
buy amoxil without prescription
augmentin for sale
buy augmentin without prescription
bactrim for sale
buy bactrim without prescription
biaxin for sale
buy biaxin without prescription
buy cipro without prescription
cipro for sale
buy cleocin without prescription
cleocin for sale
buy dexone without prescription
dexone for sale
buy flagyl without prescription
flagyl for sale
buy levaquin without prescription
levaquin for sale
buy omnicef without prescription
omnicef for sale
amaryl for sale
buy amaryl without prescription
buy cozaar without prescription
cozaar for sale
buy diabecon without prescription
diabecon for sale
buy glucophage without prescription
glucophage for sale
buy glucotrol without prescription
glucotrol for sale
buy glucovance without prescription
glucovance for sale
buy micronase without prescription
micronase for sale
buy prandin without prescription
prandin for sale
buy precose without prescription
precose for sale
buy cialis professional without prescription
cialis professional for sale
buy cialis soft without prescription
cialis soft for sale
buy cialis super active without prescription
cialis super active for sale
buy cialis without prescription
cialis for sale
buy levitra without prescription
levitra for sale
buy viagra professional without prescription
viagra professional for sale
buy viagra soft without prescription
viagra soft for sale
buy viagra super active without prescription
viagra super active for sale
buy viagra super force without prescription
viagra super force for sale
buy viagra without prescription
viagra for sale
buy celebrex without prescription
celebrex for sale
buy colcrys without prescription
colcrys for sale
buy feldene without prescription
feldene for sale
buy imitrex without prescription
imitrex for sale
buy inderal without prescription
inderal for sale
buy indocin without prescription
indocin for sale
buy naprosyn without prescription
naprosyn for sale
buy pletal without prescription
pletal for sale
buy robaxin without prescription
robaxin for sale
buy voltaren without prescription
voltaren for sale

3 hospitals, UA and med school create BioInnovation Institute in Akron, a multimillion-dollar medical research program

Last 5 posts by Ed Morrison

You might also like:

7 Responses to “Akron’s new BioInnovation Institute”

  1. Justin Balck Says:

    For a $200M investment, I don’t think getting research grants will yield any sustainable return. Federal grants are on the downswing even for established institutions much less a newcomer. Future state of Ohio funding is limited and may be less apt to continue to pour money into the NE section of the state.

    Whether spin off companies can make up the difference is in question given NEO’s past performance, the current investment climate and an unclear connection between the spin offs and BioInnovation.

  2. Ed Morrison Says:

    Justin:

    Given your predictions, it will be interesting to see how the voters respond in Kansas to this initiative:

    http://snurl.com/4kkam

  3. Justin Balck Says:

    The Kansas initiative can produce revenue through tuition and clinical trials fees. They are offering discrete “products” versus BioI.

    To paraphrase someone’s lament regarding the convention center: “Where’s the business plan? Where’s the analysis?”

  4. Ed Morrison Says:

    Justin:

    It seems to me that the Akron initiative is pretty well thought out…

    Another big distinction. The Akron initiative is investing in growing markets. The convention business is mature and very slow growth (if not declining).

    From the press reports:

    • The Orthopaedic Research Institute of Northeast Ohio — will study and develop products and treatments for bone and joint problems.

    • The Center for Health Care Training — will train medical students and professionals, emergency medical technicians, psychiatric social workers and others, using simulation, computer modeling and standard patients.

    • The Center for Clinical Trials — will collaborate on projects and bring the newest treatments to local patients, first focusing on orthopedics but eventually expanding to other areas.

    • The Medical Device Concept Laboratory — will focus on developing medical devices.

    • The Center for Biomaterials and Medicine — will pair the polymer expertise at the university with the skeletal biology, musculoskeletal medicine and orthopedics strengths at the medical school and hospitals. (The initial focus is orthopedics but will expand to other areas, such as healing wounds.)

  5. J Murray Says:

    Justin, the name of the game in developing technologies and spinoff companies is volume. Nobody can peer into the future and predict which, if any, of a portfolio of technologies and companies will be the big winners that produce wealth, jobs, and stable regional economies. Therefore, big ideas and big investments are required to prime the pump, especially in regions that missed the last couple of technology-enabled growth cycles.

    The private sector provides limited funding to earliest technology development, leaving this as the province of federal and, increasingly, state resources. When it comes to accessing federal and state grants, multi-institution collaboration and scale matter greatly in the competition with other regions of the country for federal money.

    This is a much better use of taxpayer resources than nearly everything else that government does, because it creates technologies, attracts the best-and-brightest, and primes the pump for the private sector to do what it does best.

  6. Justin Balck Says:

    I am temporarily blinded by having J Murray and Ed Morrison in agreement!

    All of these BioI assets are redundant in the region. In addition, everything except the Clinical Trial center is competing for the same declining pot of federal research funds. Hence the need for “bridge” funding by the local philanthropists. How can a return on the $200M be achieved in such a crowded and declining market?

    This money is not being used to prime the pump but add to existing infrastructure and multiple layers of administration.

  7. J Murray Says:

    Justin, without having drilled into the details, this doesn’t seem redundant to me. There is a nexus of expertise in polymers and orthopedics in the Akron area that isn’t replicated elsewhere, certainly not in Cleveland-area institutions. The Cleveland Clinic does have a good orthopedics group, but it doesn’t have polymers. I don’t think there is a focus on orthopedics and structural human engineering at the Case School of Biomedical Engineering.

    Yes, there is always an administrative rake-off in all of these, and any government program, and that’s annoying, but probably unavoidable. The research and technology themselves, though, seem to be additive to the region.

    More importantly, this region is competing nationally against other regions, and the size of regional and statewide commitments matters in attracting federal funding, talent, and companies.